Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
BiondVax

BiondVax

BiondVax is a company founded in 2003 by Dr. Ron Babecoff.

BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. Since its inception, the company has executed eight clinical trials including a seven country, 12,400 participant Phase 3 trial of its vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms, beginning with an innovative nanosized antibody (NanoAb) pipeline.

BiondVax’s team includes scientists, technicians, researchers, and administrative staff. The company’s state-of-the-art GMP facility in Israel houses its laboratories, production facilities and offices.

Timeline

June 19, 2017
BiondVax raises a $22,280,000 private equity from European Investment Bank.
September 9, 2014
BiondVax raises a $1,300,000 grant from Office of the Chief Scientist.

Funding rounds

Patents

Further Resources

Title
Author
Link
Type
Date

References

Golden logo
By using this site, you agree to our Terms & Conditions.